Dionysios Mitropoulos
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Results of rotational thromboelastometry confirm venous thromboembolic risk prediction in urologic patients.
Journal: Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
Published: November 03, 2025
Incidental Finding of an Inflammatory Myofibroblastic Tumor of the Urinary Bladder: A Case Report.
Journal: Cureus
Published: August 13, 2025
Comparative evaluation of venous thromboembolic risk in urologic inpatients using different risk assessment models.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: April 10, 2025
The Influence of 3D Technology Integration on Laparoscopic Partial Nephrectomy Practice and Surgical Outcomes.
Journal: Current oncology (Toronto, Ont.)
Published: March 08, 2025
Evaluating the Link Between Preoperative Comorbidities and the Risk of Venous Thromboembolism in Patients Undergoing Urological Surgery.
Journal: Cureus
Published: February 08, 2025
Fusion MRI/Ultrasound-Guided Transperineal Biopsy: A Game Changer in Prostate Cancer Diagnosis.
Journal: Journal of clinical medicine
Published: November 30, 2024
Retrospective, Non-Interventional, Multicenter Study on the Effectiveness and Safety of Intravesical Bacillus Calmette-Guerin in Patients with Non-Muscle-Invasive Bladder Cancer: Real-World Experience from Six Hospital Centers in Greece.
Journal: Current oncology (Toronto, Ont.)
Published: November 15, 2024
Magnetic resonance imaging/ultrasound fusion-guided transperineal prostate biopsy: Protocol for a clinic-based surgical technique.
Journal: Journal of biological methods
Published: November 11, 2024
Do we need a patient surgical class categorization similar to the American Society of Anesthesiologists (ASA) grade?
Journal: World journal of surgery
Published: August 24, 2024
Intravesical Administration of Durvalumab for High-risk Non-muscle-invasive Bladder Cancer: A Phase 2 Study by the Hellenic GU Cancer Group.
Journal: European urology
Published: July 30, 2024
Last Updated: 09/26/2026